Ibandronate- Monthiba Tab 1s

Information About Ibandronate- Monthiba Tab 1s

About Ibandronate- Monthiba Tab 1s

The Medicine Brand MONTHIBA TAB 1S is manufactured by Panacea Biotec Ltd and mainly contents the generic drug Ibandronate.

Pakaging

1SX1

Active Ingredients For Ibandronate- Monthiba Tab 1s

Ibandronate 150 mg

Diseases List For Which Ibandronate- Monthiba Tab 1s Is Prescribed

This Drug Is Prescribed For osteoporosis

Other Significations For Ibandronate- Monthiba Tab 1s

This Medication Ibandronate is an oral and intravenous drug that is used for treating osteoporosis It is a member of the bisphosphonate class of drugs which includes etidronate Didronel pamidronate Aredia risedronate Actonel and tiludronate Skelid Bone is in a constant state of remodeling New bone is laid down by cells called osteoblasts while old bone is removed by cells called osteoclasts Bisphosphonates strengthen bone by inhibiting bone removal resorption by osteoclasts After menopause there is an increased rate of bone loss leading to osteoporosis and ibandronate has been shown to increase bone density and decrease fractures of bones FDA approved ibandronate in May 2003

Precautions To Be Taken Before Ibandronate- Monthiba Tab 1s

Calcium supplements antacids and other products that contain aluminum magnesium or iron may reduce absorption of ibandronate Ibandronate should be administered at least 60 minutes before administration of any oral medication including medications containing iron aluminum magnesium or calcium Patients should wait at least 60 minutes after taking ibandronate before taking other oral medications The occurrence of irritation in the stomach and intestines may increase if aspirin and other nonsteroidal antiinflammatory drugs for example Motrin Aleve are combined with ibandronate

Major Conditions And Care

Pregnancy And Ibandronate- Monthiba Tab 1s

Can We Take Ibandronate- Monthiba Tab 1s During Pregnancy?

Pregnancy Class C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and wellcontrolled studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks

Lactation And Ibandronate- Monthiba Tab 1s

Can We Use Ibandronate- Monthiba Tab 1s During Lactation

Lactation Class L4 There is positive evidence of risk to a breastfed infant or to breastmilk production but the benefits of use in breastfeeding mothers may be acceptable despite the risk to the infant eg if the drug is needed in a lifethreatening situation or for a serious disease for which safer drugs cannot be used or are ineffective

Side Effects Of Ibandronate- Monthiba Tab 1s

Nausea stomach upset skin rash acute toxicity

More Danger Effects Fatal Effect Due To Overdose Of Ibandronate- Monthiba Tab 1s